The U.S. Food and Drug Administration recently approved Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) for ...
In September 2025, Merck received FDA approval for KEYTRUDA QLEX, a subcutaneous version of its flagship cancer therapy, allowing for one- to two-minute administration across 38 solid tumor ...
FDA approves Bravecto Quantum (fluralaner), the first annual injection against fleas and ticks in dogs, offering 12 months of ...
Keytruda Qlex, a subcutaneous formulation, is FDA-approved for solid tumors in patients 12 and older, offering an alternative to intravenous administration. Study MK-3475A-D77 showed comparable ...
SQ Innovation, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its drug-device combination ...
Equity Insider News Commentary Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Oct. 17, 2025 /PRNewswire/ -- Equity InsiderNews Commentary – MIT and ...
Ozempic (semaglutide) is a prescription drug that works in various ways. These include mimicking GLP-1 to help stimulate the pancreas to release insulin and lowering the amount of sugar released into ...
A door supervisor has said a life-saving drug should be carried as standard by security staff, after he helped a man during an overdose. Charlie Smith used a syringe filled with naloxone to reverse ...
A door supervisor has said a life-saving drug should be carried as standard by security staff, after he helped a man during an overdose. Charlie Smith used a syringe filled with naloxone to reverse ...
I believe that Merck (NYSE:MRK) is a good long-term pharmaceutical company to own and with that being said, it is because of several excellent moves it has made in the last few years. The first major ...
“The CDC recommendation trumps the label,” said Dorit Reiss, a vaccine law expert at the University of California’s law ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback